BIOMAT Database Logo BIOMAT Database Logo

Optimization of a fed-batch process for production of a recombinant antibody. 1994

D K Robinson, and T C Seamans, and S L Gould, and D J DiStefano, and C P Chan, and D K Lee, and T Bibila, and K Glazomitsky, and S Munshi, and B Daugherty
Merck Research Laboratories, Rahway, New Jersey 07065.

UI MeSH Term Description Entries
D007143 Immunoglobulin Heavy Chains The largest of polypeptide chains comprising immunoglobulins. They contain 450 to 600 amino acid residues per chain, and have molecular weights of 51-72 kDa. Immunoglobulins, Heavy-Chain,Heavy-Chain Immunoglobulins,Ig Heavy Chains,Immunoglobulin Heavy Chain,Immunoglobulin Heavy Chain Subgroup VH-I,Immunoglobulin Heavy Chain Subgroup VH-III,Heavy Chain Immunoglobulins,Heavy Chain, Immunoglobulin,Heavy Chains, Ig,Heavy Chains, Immunoglobulin,Immunoglobulin Heavy Chain Subgroup VH I,Immunoglobulin Heavy Chain Subgroup VH III,Immunoglobulins, Heavy Chain
D007147 Immunoglobulin Light Chains Polypeptide chains, consisting of 211 to 217 amino acid residues and having a molecular weight of approximately 22 kDa. There are two major types of light chains, kappa and lambda. Two Ig light chains and two Ig heavy chains (IMMUNOGLOBULIN HEAVY CHAINS) make one immunoglobulin molecule. Ig Light Chains,Immunoglobulins, Light-Chain,Immunoglobulin Light Chain,Immunoglobulin Light-Chain,Light-Chain Immunoglobulins,Chains, Ig Light,Chains, Immunoglobulin Light,Immunoglobulins, Light Chain,Light Chain Immunoglobulins,Light Chain, Immunoglobulin,Light Chains, Ig,Light Chains, Immunoglobulin,Light-Chain, Immunoglobulin
D010954 Plasmacytoma Any discrete, presumably solitary, mass of neoplastic PLASMA CELLS either in BONE MARROW or various extramedullary sites. Plasma Cell Tumor,Plasmocytoma,Plasma Cell Tumors,Plasmacytomas,Plasmocytomas,Tumor, Plasma Cell,Tumors, Plasma Cell
D011401 Promoter Regions, Genetic DNA sequences which are recognized (directly or indirectly) and bound by a DNA-dependent RNA polymerase during the initiation of transcription. Highly conserved sequences within the promoter include the Pribnow box in bacteria and the TATA BOX in eukaryotes. rRNA Promoter,Early Promoters, Genetic,Late Promoters, Genetic,Middle Promoters, Genetic,Promoter Regions,Promoter, Genetic,Promotor Regions,Promotor, Genetic,Pseudopromoter, Genetic,Early Promoter, Genetic,Genetic Late Promoter,Genetic Middle Promoters,Genetic Promoter,Genetic Promoter Region,Genetic Promoter Regions,Genetic Promoters,Genetic Promotor,Genetic Promotors,Genetic Pseudopromoter,Genetic Pseudopromoters,Late Promoter, Genetic,Middle Promoter, Genetic,Promoter Region,Promoter Region, Genetic,Promoter, Genetic Early,Promoter, rRNA,Promoters, Genetic,Promoters, Genetic Middle,Promoters, rRNA,Promotor Region,Promotors, Genetic,Pseudopromoters, Genetic,Region, Genetic Promoter,Region, Promoter,Region, Promotor,Regions, Genetic Promoter,Regions, Promoter,Regions, Promotor,rRNA Promoters
D011993 Recombinant Fusion Proteins Recombinant proteins produced by the GENETIC TRANSLATION of fused genes formed by the combination of NUCLEIC ACID REGULATORY SEQUENCES of one or more genes with the protein coding sequences of one or more genes. Fusion Proteins, Recombinant,Recombinant Chimeric Protein,Recombinant Fusion Protein,Recombinant Hybrid Protein,Chimeric Proteins, Recombinant,Hybrid Proteins, Recombinant,Recombinant Chimeric Proteins,Recombinant Hybrid Proteins,Chimeric Protein, Recombinant,Fusion Protein, Recombinant,Hybrid Protein, Recombinant,Protein, Recombinant Chimeric,Protein, Recombinant Fusion,Protein, Recombinant Hybrid,Proteins, Recombinant Chimeric,Proteins, Recombinant Fusion,Proteins, Recombinant Hybrid
D003587 Cytomegalovirus A genus of the family HERPESVIRIDAE, subfamily BETAHERPESVIRINAE, infecting the salivary glands, liver, spleen, lungs, eyes, and other organs, in which they produce characteristically enlarged cells with intranuclear inclusions. Infection with Cytomegalovirus is also seen as an opportunistic infection in AIDS. Herpesvirus 5, Human,Human Herpesvirus 5,Salivary Gland Viruses,HHV 5,Herpesvirus 5 (beta), Human,Cytomegaloviruses,Salivary Gland Virus,Virus, Salivary Gland,Viruses, Salivary Gland
D005786 Gene Expression Regulation Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control (induction or repression) of gene action at the level of transcription or translation. Gene Action Regulation,Regulation of Gene Expression,Expression Regulation, Gene,Regulation, Gene Action,Regulation, Gene Expression
D005813 Genes, Synthetic Biologically functional sequences of DNA chemically synthesized in vitro. Artificial Genes,Synthetic Genes,Artificial Gene,Gene, Artificial,Gene, Synthetic,Genes, Artificial,Synthetic Gene
D005822 Genetic Vectors DNA molecules capable of autonomous replication within a host cell and into which other DNA sequences can be inserted and thus amplified. Many are derived from PLASMIDS; BACTERIOPHAGES; or VIRUSES. They are used for transporting foreign genes into recipient cells. Genetic vectors possess a functional replicator site and contain GENETIC MARKERS to facilitate their selective recognition. Cloning Vectors,Shuttle Vectors,Vectors, Genetic,Cloning Vector,Genetic Vector,Shuttle Vector,Vector, Cloning,Vector, Genetic,Vector, Shuttle,Vectors, Cloning,Vectors, Shuttle
D005974 Glutamate-Ammonia Ligase An enzyme that catalyzes the conversion of ATP, L-glutamate, and NH3 to ADP, orthophosphate, and L-glutamine. It also acts more slowly on 4-methylene-L-glutamate. (From Enzyme Nomenclature, 1992) EC 6.3.1.2. Glutamine Synthetase,Glutamate Ammonia Ligase (ADP),Glutamate Ammonia Ligase,Ligase, Glutamate-Ammonia,Synthetase, Glutamine

Related Publications

D K Robinson, and T C Seamans, and S L Gould, and D J DiStefano, and C P Chan, and D K Lee, and T Bibila, and K Glazomitsky, and S Munshi, and B Daugherty
A fully defined, fed-batch, recombinant NS0 culture process for monoclonal antibody production.
January 2010, Biotechnology progress,
D K Robinson, and T C Seamans, and S L Gould, and D J DiStefano, and C P Chan, and D K Lee, and T Bibila, and K Glazomitsky, and S Munshi, and B Daugherty
A high-yielding, generic fed-batch process for recombinant antibody production of GS-engineered cell lines.
December 2009, Journal of microbiology and biotechnology,
D K Robinson, and T C Seamans, and S L Gould, and D J DiStefano, and C P Chan, and D K Lee, and T Bibila, and K Glazomitsky, and S Munshi, and B Daugherty
Optimization for a recombinant E. coli fed-batch fermentation.
January 1995, Applied biochemistry and biotechnology,
D K Robinson, and T C Seamans, and S L Gould, and D J DiStefano, and C P Chan, and D K Lee, and T Bibila, and K Glazomitsky, and S Munshi, and B Daugherty
In pursuit of the optimal fed-batch process for monoclonal antibody production.
January 1995, Biotechnology progress,
D K Robinson, and T C Seamans, and S L Gould, and D J DiStefano, and C P Chan, and D K Lee, and T Bibila, and K Glazomitsky, and S Munshi, and B Daugherty
A high-yielding, generic fed-batch cell culture process for production of recombinant antibodies.
March 2000, Biotechnology and bioengineering,
D K Robinson, and T C Seamans, and S L Gould, and D J DiStefano, and C P Chan, and D K Lee, and T Bibila, and K Glazomitsky, and S Munshi, and B Daugherty
Medium and feed optimization for fed-batch production of a monoclonal antibody in CHO cells.
January 2011, BMC proceedings,
D K Robinson, and T C Seamans, and S L Gould, and D J DiStefano, and C P Chan, and D K Lee, and T Bibila, and K Glazomitsky, and S Munshi, and B Daugherty
Recombinant bioprocess optimization for heterologous protein production using two-stage, cyclic fed-batch culture.
May 1998, Applied microbiology and biotechnology,
D K Robinson, and T C Seamans, and S L Gould, and D J DiStefano, and C P Chan, and D K Lee, and T Bibila, and K Glazomitsky, and S Munshi, and B Daugherty
Optimization of fed-batch production of the model recombinant protein GFP in Lactococcus lactis.
April 2007, Biotechnology and bioengineering,
D K Robinson, and T C Seamans, and S L Gould, and D J DiStefano, and C P Chan, and D K Lee, and T Bibila, and K Glazomitsky, and S Munshi, and B Daugherty
Fed-batch culture of recombinant NS0 myeloma cells with high monoclonal antibody production.
September 1997, Biotechnology and bioengineering,
D K Robinson, and T C Seamans, and S L Gould, and D J DiStefano, and C P Chan, and D K Lee, and T Bibila, and K Glazomitsky, and S Munshi, and B Daugherty
Comparison of various optimization approaches for fed-batch ethanol production.
August 1999, Applied biochemistry and biotechnology,
Copied contents to your clipboard!